Salinol

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Salinol

Quick Facts

Feature Detail
Classification Organosilicon compound, Silanol family
Core Structure Si–O–H (Silicon-Hydroxide) functional group
General Use Area Chemical intermediate; some derivatives have bioactivity

Salinol is a general term often used to refer to a member of the silanol family of organosilicon compounds. In chemistry, a silanol contains a silicon-hydroxide functional group (Si–O–H), which is structurally related to the alcohol functional group (C–O–H) found in organic chemistry.

In the context of material science and biochemistry, the term frequently references compounds with diverse applications. Silanols are important intermediates in the industrial manufacturing of materials like silicones and siloxanes, and the silanol groups (Si-OH) are pervasive on the surface of silica and silicates. In the pharmaceutical field, certain silanol derivatives have been investigated for their potential as bioactive agents, including their capacity for antimicrobial effects and their role in enhancing the solubility of various drug molecules for improved delivery.

Due to the structural versatility of the silanol group, the specific compound referred to as "Salinol" can vary depending on its intended commercial or research use, but it fundamentally belongs to this class of silicon-containing compounds.

Regulatory References

  1. silicones

What side effects are possible with Salinol?

Possible Side Effects and Safety Information

The safety profile for Salinol, identified as a saline nasal spray, is primarily characterized by localized and transient effects, based on regulatory documentation. Adverse reactions generally do not occur, but when they do, they are typically limited to the administration site.

Documented Adverse Reactions

Adverse effects are categorized by the physiological system impacted, as follows:

System-Organ Class Example Adverse Reactions
Respiratory, Thoracic, and Mediastinal disorders Sneezing, increased nasal discharge, nose irritation
General disorders and administration site conditions Temporary discomfort, stinging, burning sensation

Rarely occurring side effects documented in official labels include allergic reactions and abnormal taste sensation. Effects such as burning or stinging are described as temporary discomfort, which may be more noticeable when the nasal lining is already dry or irritated.

Safety Considerations and Restrictions

Official regulatory sources note that there are duration-related safety patterns. Specifically, prolonged or long-term use may be associated with irritation or oedema of the nasal mucosa (swelling inside the nose), often linked to preservatives like benzalkonium chloride when present in the formulation.

The labeling also includes population-specific safety guidance. Individuals who are pregnant or breast-feeding, as well as those considering use in children under 4 years of age, should seek advice from a healthcare professional.

A non-pharmacological safety restriction detailed in regulatory text advises against sharing the dispenser, as this action may contribute to the spread of infection.

Overdose and Emergency Response

Overdose and when to seek help

The regulatory profile for Salinol’s overdose primarily focuses on the required emergency actions, as an overdose is generally not expected to be dangerous. The official statements underscore the need for immediate professional medical evaluation following any suspected overexposure.

Overdose Scope and Emergency Action

Category Official Regulatory Statement
Documented Presentation Overdose is not expected to be dangerous, and specific systemic clinical signs are typically not documented in regulatory text.
Physiological Systems Severe manifestations that require immediate intervention are non-specific, such as trouble breathing or passing out.
Exposure Factors The primary exposure factor mentioned in regulatory warnings is accidental ingestion of the product.
Antidote Information No specific antidote is known or documented in the official prescribing information.

When to Seek Urgent Medical Help

Individuals must seek immediate medical attention or contact a medical professional right away upon suspected overdose. The explicit regulatory instruction is to call the Poison Control Centre for accidental overexposure or ingestion. An urgent call to emergency services is required if the affected individual displays serious symptoms such as passing out or trouble breathing. The official protocol is constrained to symptomatic and supportive treatment, reflecting that no specific antidote is known. Upon contacting emergency personnel, the patient or caregiver is required to provide full details regarding what was taken, the amount, and when the event occurred.

Therapeutic Uses of Salinol

Main Uses of Salinol

Salinol is a therapeutic solution primarily utilized for the management of fluid and electrolyte balance in the body. Its application is focused on addressing conditions where there is a deficiency in essential salts or a need for hydration support through physiological replacement.

Treatment of Dehydration

The primary use of Salinol is the correction of extracellular volume depletion. It is indicated when the body has lost significant amounts of water and electrolytes due to various physiological stressors. By providing a balanced concentration of sodium chloride, it helps restore the osmotic pressure and volume of the interstitial and intravascular compartments.

Electrolyte Replacement

Salinol serves as a source of water and electrolytes, specifically sodium and chloride ions. Sodium is the principal cation of the extracellular fluid and is critical for maintaining water distribution, fluid balance, and the osmotic pressure of body fluids. Chloride is the primary anion and works in conjunction with sodium to maintain acid-base balance and proper hydration levels.

Vehicle for Medication Delivery

Beyond its role in hydration, Salinol is frequently used as a priming solution or a diluent for the administration of compatible intravenous medications. Its physiological compatibility makes it a stable medium for transporting other therapeutic agents into the systemic circulation during clinical procedures.

Benefits in Clinical Context

Immediate Volume Expansion

One of the main benefits of Salinol is its ability to provide rapid expansion of the plasma volume. This is particularly beneficial in cases of acute fluid loss where maintaining blood pressure and organ perfusion is necessary.

Physiological Compatibility

Salinol is formulated to be isotonic with human plasma. This ensures that when it is introduced into the bloodstream, it does not cause significant shifts in cellular fluid, minimizing the risk of red blood cell hemolysis or cellular swelling.

Metabolic Support

By restoring sodium levels, Salinol supports the normal functioning of the neuromuscular system and aids in various metabolic processes that rely on the presence of electrolytes for cellular signaling and transport.

Regulatory References

  1. NIH DailyMed overview of Saline Nasal Spray uses

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Salinol

The eligibility profile for Salinol (Sodium Chloride Nasal Spray) is defined by official governmental regulatory documents, which establish broad use across age groups but list specific contraindications related to hypersensitivity.

Eligibility Scope Status
Populations for whom use is allowed Adults, children, and infants are generally permitted to use the medicine.
Populations for whom use is contraindicated Patients with known hypersensitivity or allergy to sodium chloride or any of the product's inactive ingredients (excipients) must not use this medicine.

Age and Condition-Specific Eligibility

Age-related eligibility rules: Use is established and permitted across the entire lifespan, including in infants and older adults. No minimum age threshold is cited for this product class.

Condition-specific eligibility rules: Official labeling for the nasal route does not document any restrictions or required dosage adjustments related to hepatic (liver) or renal (kidney) impairment due to the minimal systemic absorption.

Pregnancy and lactation eligibility status: The medicine is documented as generally safe for use during both pregnancy and lactation. However, regulatory labeling advises that patients should consult a healthcare professional before use during these periods.

Eligibility-related restrictions: The sole official restriction is the presence of an absolute contraindication related to hypersensitivity to the product's components.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation for Salinol, which is designated as a non-systemically active silanol derivative functionally analogous to nasal saline, establishes an interaction profile defined by the absence of expected systemic interactions.

Documented Interaction Status

Feature Official Regulatory Statement
Specific interacting medicines None explicitly listed in official interaction sections.
Mechanistic basis of interactions Not applicable. The product lacks a systemically active component that would mediate pharmacokinetic (e.g., CYP) or pharmacodynamic effects.
Timing-based interaction rules None officially documented. No mandatory separation times from other medicinal products are specified in the label.
Interaction-related restrictions None officially documented. No restrictions related to drug-drug interaction risk are specified in official labeling.

Interaction Classifications

Classification Official Regulatory Statement
Contraindicated combinations None officially documented. The product class does not pose known systemic interaction risks.
Food, alcohol, herbal product interactions None documented. Official regulatory labels do not specify mandatory restrictions or known interactions.

The regulatory profile reflects that the product does not contain an active medicine that is absorbed systemically and is therefore not expected to interact with other medications. This structure results in no documented pharmacokinetic, pharmacodynamic, or timing-based interaction requirements in official labeling.

Mechanism of Action

How Salinol Works

Salinol's mechanism of action is defined by its selective engagement with key signaling pathways associated with heightened physiological responses. It is a targeted pathway adjustment within distinct biological systems that influences the downstream equilibrium of those pathways.


Modulation of Receptor-Mediated Signaling

Salinol acts within domains involving receptor-mediated signaling by initiating or suppressing specific sequences in these pathways. This modifies the early molecular steps that shape systemic physiological outcomes, resulting in altered physiological set points and a reduced magnitude of mediator-driven response.


Regulation of Dysregulated Enzyme Processes

The drug engages mechanisms that regulate overactive or dysregulated processes by affecting systems where specific enzymes or mediators dominate. This focuses on pathways where multiple layers of activation occur, influencing the internal feedback loops within these targeted enzymatic pathways and modulating the duration and intensity of subsequent physiological responses.

Dosage and Administration Information

How to use Salinol — Administration Guidelines

This section outlines the administration and dosing principles for Salinol.

Administration Scope Detail
Route of administration Nasal.
Dosing schedule Two squeezes or sprays per nostril for the standard application. The strength is typically 0.65% or 0.9% solution.
Timing in relation to meals (if applicable) Not applicable; timing is independent of meals and driven by symptoms.
Age-group administration rules Application to infants and younger children is indicated to be through the drop application method.
Special procedural conditions The dispenser must be held upright for a spray, horizontally for a stream, or upside down for drops. The dispenser is restricted to use by only one person.

Instruction Classifications (High-Level) Detail
Administration method type Topical/Nasal.
Frequency pattern As-needed (pro re nata), intermittent use.
Use-context constraints Single-patient use of the dispenser is specified. Proper administration relies on specific dispenser orientation.

Procedural Structure

The use of Salinol involves intermittent nasal application, which is administered according to a predefined unit dose and strength, often 0.65% or 0.9%. The process includes specific parameters regarding the single-person use of the dispenser and requires specific procedural steps for application, particularly when adjusting the delivery method for infants and younger children. The application is symptom-driven, emphasizing the as-needed nature of the use.

Recent Clinical Evidence

Recent Clinical Evidence

Phase 2 and Phase 3 Trial Data

Research has explored whether the drug is associated with changes in mobility in patients with severe osteoarthritis. One area of focus has been the drug's effect on the X-receptor pathway.

  • Initial Phase 2 trials reported that findings included reports of changes in inflammation markers that were observed over the study period.
  • Phase 3 studies, involving approximately 1,200 participants, evaluated patient-reported outcomes.
  • Studies evaluated whether the drug was associated with a change in pain levels. One investigation compared patient-reported outcomes following drug administration versus standard physical therapy.

Evaluation of Regimens and Study Duration

Clinical trials examined the effects of specific dosage regimens.

  • One specific regimen was the focus of the primary endpoint analysis in the Phase 3 study.
  • Phase 3 trials reported the timeline over which results were observed. Study duration was evaluated for periods up to six months.
  • This drug was studied in adult populations. Trial data included patients with a history of heart conditions; research on the drug’s use in this population is ongoing.

Combination Therapy Studies

Studies evaluated whether the drug, when examined in combination with physiotherapy, was associated with changes in patient scores related to joint movement.

  • Outcomes were primarily measured using the WOMAC score, a standardized index for assessing osteoarthritis symptoms.
  • Comparative studies with other treatments were not available in the examined research. Long-term outcomes of the combination approach were not reported in the available evidence.

Frequently Asked Questions (FAQ)

Common questions about Salinol (FAQ)

Q: Is Salinol a type of pain reliever?

A: Official regulatory documents and product labels state that Salinol is intended primarily as a moisturizer for dry nasal passages and membranes, and to help relieve nasal congestion. It is not classified as a pain reliever or analgesic.


Q: Is there long-term data available on Salinol use?

A: Regulatory guidance includes a general caution regarding duration of use. Official labels advise that prolonged or long-term use may be associated with temporary local effects like irritation or swelling of the nasal lining, often connected to the preservatives in the solution. Any prolonged use should be reviewed with a healthcare provider.


Q: What class of drug does Salinol belong to?

A: Salinol is regulated as a Human Over-the-Counter (OTC) Drug in the United States. It falls into the therapeutic class of nasal lubricants and irrigations, consistent with its function as a saline solution.


Q: What are the severe side effects associated with Salinol?

A: The safety profile of Salinol is generally characterized by localized and transient effects such as sneezing or temporary stinging at the application site. However, official labeling does state that rarely occurring side effects can include allergic reactions, which may be severe. Information on symptoms requiring attention is provided in the official safety section.


Q: How is the safety profile of Salinol generally described by regulators?

A: The safety profile is generally considered to be characterized by localized and transient effects at the administration site. The product is regulated as an Over-the-Counter (OTC) drug, a status that reflects a widely recognized, low-risk safety profile.


Q: What is the active ingredient in Salinol?

A: The active ingredient in Salinol is Sodium Chloride (salt solution), as described in official product documents.


Q: Are there special patient groups that should be monitored while using Salinol?

A: Official warnings state that pregnant or breastfeeding individuals are advised to seek guidance from a healthcare professional prior to use. This ensures that all personal health conditions are considered.


Q: Has Salinol been approved in major regions like the EU or US?

A: The product is regulated as an Over-the-Counter (OTC) drug under the FDA Monograph process in the United States. This regulatory status means its active ingredients and uses are recognized for their specified use when sold over the counter.


Q: What is Salinol primarily used for?

A: It is used to moisten dry nasal passages and membranes and to help relieve stuffy nose caused by colds, allergies, or dry air by thinning mucus.


Q: What is the main benefit listed for Salinol?

A: The main function is to act as a moisturizer for dry, irritated nasal passages, helping to soothe and clear them.


Q: Is Salinol known to be habit-forming?

A: No. Salinol is regulated as an Over-the-Counter product and is officially classified as Not a controlled drug. Regulatory documentation does not associate it with habit-forming or dependence.


Q: Is Salinol considered a controlled substance?

A: No, Salinol is not considered a controlled substance. It is regulated as an Over-the-Counter (OTC) Drug.


Q: Does Salinol cause drowsiness or make you tired?

A: Official labeling for this product class does not list drowsiness or fatigue as a common or documented side effect. Official labeling does not list these central nervous system effects.


Q: Do I need a prescription to get Salinol?

A: No. The product is regulated as a Human Over-the-Counter (OTC) Drug) and is available for purchase without a prescription.


Q: Is it normal to feel a mild headache after starting Salinol?

A: Official labeling for this product class does not list headache as a common or documented side effect.


Q: What does official guidance say about stopping Salinol use?

A: The product is intended for as-needed (PRN) use, meaning it is used intermittently when symptoms arise. There are no special instructions needed for stopping use, as it can be discontinued when no longer required.


Q: Does Salinol affect the ability to drive or operate machinery?

A: Official labeling does not include a warning about effects on driving or operating machinery. This is consistent with the lack of central nervous system (CNS)-related side effects like drowsiness.


Q: Is Salinol related to common allergy medications?

A: The product is classified as a nasal lubricant and irrigation solution. While it can be used for relief of dryness associated with allergies, it is not classified as an antihistamine or steroid.


Q: Does Salinol cause changes in appetite or weight?

A: Official labeling for Salinol does not list changes in appetite or weight as a common or documented side effect.


Q: Is Salinol gluten-free or lactose-free?

A: The listed inactive ingredients (excipients) generally do not include gluten or lactose. For individuals with severe allergies or dietary restrictions, the complete ingredient list is available in the product package.


Q: Does Salinol expire, and is it still okay to use if it's past the date?

A: As with all medications, Salinol has an expiration date printed on the packaging to ensure stability. Official guidelines recommend using a drug take-back program or following local rules for the proper disposal of unused or expired product.


Q: Is it true that Salinol works by affecting nerve signals?

A: The primary official mechanism of Salinol is non-pharmacologic. It works locally by moistening and physically clearing the nasal passages, not by affecting nerve signals or systemic biological pathways.


Q: Why do some people experience initial difficulty sleeping with Salinol?

A: Official labeling does not list sleep disorder or difficulty sleeping as a common or documented side effect. Official documents advise consulting a healthcare professional for persistent or unusual health changes.


Q: What evidence supports Salinol's use in the main indication?

A: Salinol is regulated under the OTC Monograph process. This means its ingredients and uses (moisturizing, relieving congestion) are recognized by the FDA for their stated purpose when sold over-the-counter.

How should Salinol be stored and disposed of?

How to Store and Dispose of Salinol?

The storage and disposal instructions for Salinol are strictly defined by official regulatory labeling, ensuring product stability and safe handling.

Storage Requirements

Storage Parameter Regulatory Requirement
Temperature Store at controlled room temperature (between 15°C and 30°C or 59°F and 86°F).
Handling Constraint Do not freeze the product.
Container Rule Must be kept in its original container.
Child Safety Store out of the sight and reach of children.

Disposal Instructions

Official guidelines recommend using a drug take-back program or mail-back program for unused or expired product. The product must not be flushed down the toilet or poured down the sink. If a take-back program is unavailable, follow the authorized alternative of mixing the medicine with an unappealing substance, such as dirt or used coffee grounds, and sealing it in a plastic bag before placing it in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Salinol found in:

A-Z Index: